Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolenceCataplexy, Disorders of Excessive Somnolence, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, Sleepiness, narcolepsy, narcolepsy without cataplexy, narcolepsy-cataplexy syndrome, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 2 / Phase 32026-10-02NCT07598708

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Centessa Pharmaceuticals (UK) Limited5

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atlanta, GeorgiaAtlantaUnited States3
Austin, TexasAustinUnited States2
Birmingham, AlabamaBirminghamUnited States1
Brandon, FloridaBrandonUnited States2
Cincinnati, OhioCincinnatiUnited States3
Colorado Springs, ColoradoColorado SpringsUnited States1
Columbia, South CarolinaColumbiaUnited States2
Dallas, TexasDallasUnited States1
Denver, North CarolinaDenverUnited States3
Dublin, OhioDublinUnited States2
Flowood MississippiFlowoodUnited States1
Houston, TexasHoustonUnited States1
Huntersville, North CarolinaHuntersvilleUnited States2
Miami Lakes, FloridaMiami LakesUnited States1
Miami, FloridaMiamiUnited States3
Miami, FloridaMiamiUnited States1
Miami, FloridaMiamiUnited States2
Miami, FloridaMiamiUnited States1
Orlando, FloridaOrlandoUnited States2
Rincon, GeorgiaRinconUnited States1
San Antonio, TexasSan AntonioUnited States2
St. Petersburg, FloridaSt. PetersburgUnited States1
Sugar Land, TexasSugar LandUnited States1